Original Scientific Article
PROTECTIVE EFFICACY OF A LOCALLY PREPARED BIVALENT DUCK VIRAL HEPATITIS “SEROTYPES 1 AND 3” INACTIVATED VACCINE
The spread of duck hepatitis virus (DHV) in Egypt with its’ most prevalent genotypes (1 and 3) causes vast economic losses in the duck industry despite the regular vaccination with live attenuated vaccines. However, the use of live-vaccines is considered a potential risk for the non-vaccinated birds due to the viral shedding from vaccinated populations. The current study aimed to evaluate the protective efficacy and safety of two inactivated monovalent and one bivalent vaccines against DHV 1 and 3 genotypes. The inactivated monovalent (DHAV-1, DHAV-3) and bivalent (DHAV-1+3) vaccines were produced by using Montanide ISA 70 oil as an adjuvant. Three groups of 4-week-old ducklings (n=50) were vaccinated with one of the three vaccines, respectively. One group of ducklings was used as negative control (n=25). The immune-response of the vaccinated groups was measured by Virus Neutralization Test and expressed with Neutralizing Indices (NIs). The NIs for the bivalent vaccine group (5.6 and 5.4) were higher compared to the monovalent vaccine groups (5.0 and 4.7). In conclusion, the use of inactivated bivalent DHV vaccine could produce higher protective efficacy compared to the monovalent DHAV-1 and DHAV-3 vaccines.
https://macvetrev.mk/LoadArticlePdf/378
2024-03-15
5
11
10.2478/macvetrev-2024-0010
DHAV genotype 1
DHAV genotype 3
duck hepatitis virus type I (DHAV)
inactivated duck hepatitis vaccine
Neutralization index (NI)
Dalia M.
Omar
false
1
Inactivated Viral Poultry Vaccine Department (IVPVD), Central Laboratory for Evaluation of Veterinary Biologics (CLEVB), Agricultural Research Center (ARC), Cairo 11381, Egypt
AUTHOR
Mohamed A.
Abdrabo
false
2
Inactivated Viral Poultry Vaccine Department (IVPVD), Central Laboratory for Evaluation of Veterinary Biologics (CLEVB), Agricultural Research Center (ARC), Cairo 11381, Egypt
AUTHOR
Nermin M.
Monir
false
3
Inactivated Viral Poultry Vaccine Department (IVPVD), Central Laboratory for Evaluation of Veterinary Biologics (CLEVB), Agricultural Research Center (ARC), Cairo 11381, Egypt
AUTHOR
Nermeen A.
Marden
nermeen.marden@gmail.com
false
4
Inactivated Viral Poultry Vaccine Department (IVPVD), Central Laboratory for Evaluation of Veterinary Biologics (CLEVB), Agricultural Research Center (ARC), Cairo 11381, Egypt
LEAD_AUTHOR
Heba M.G.
Abdelaziz
false
5
Inactivated Viral Poultry Vaccine Department (IVPVD), Central Laboratory for Evaluation of Veterinary Biologics (CLEVB), Agricultural Research Center (ARC), Cairo 11381, Egypt
AUTHOR
Walaa A.
ElSayed
false
6
Veterinary Serum and Vaccine Research Institute (VSVRI), Agricultural Research Center (ARC), Cairo, 11381, Egypt
AUTHOR
Nahed
Yehia
false
7
National Laboratory for Veterinary Quality Control of Poultry Production (NLQP), Animal Health Research Institute (AHRI), Agricultural Research Center (ARC), Giza 12618, Egypt
AUTHOR
Sabry E.
Omar
false
8
National Laboratory for Veterinary Quality Control of Poultry Production (NLQP), Animal Health Research Institute (AHRI), Agricultural Research Center (ARC), Giza 12618, Egypt
AUTHOR
Ahmed M.
Erfan
false
9
National Laboratory for Veterinary Quality Control of Poultry Production (NLQP), Animal Health Research Institute (AHRI), Agricultural Research Center (ARC), Giza 12618, Egypt
AUTHOR
Abdel
Satar
Arafa
false
10
National Laboratory for Veterinary Quality Control of Poultry Production (NLQP), Animal Health Research Institute (AHRI), Agricultural Research Center (ARC), Giza 12618, Egypt
AUTHOR
Momtaz A.
Shahein
false
11
National Laboratory for Veterinary Quality Control of Poultry Production (NLQP), Animal Health Research Institute (AHRI), Agricultural Research Center (ARC), Giza 12618, Egypt
AUTHOR
Lamiaa M.
Omar
false
12
Inactivated Viral Poultry Vaccine Department (IVPVD), Central Laboratory for Evaluation of Veterinary Biologics (CLEVB), Agricultural Research Center (ARC), Cairo 11381, Egypt
AUTHOR
Li, J., Bi, Y.H., Chen, C., Yang, L.M., Ding, C., Liu, W.J. (2013). Genetic characterization of duck hepatitis A viruses isolated in China. Virus Res. 178(2): 211-216. PMid:24144860
1
https://doi.org/10.1016/j.virusres.2013.10.007
ICTV, International Committee on Taxonomy of Viruses. [Internet] c2017 [cited 2017 March 15]. http://ictv.global/report
2
Ding, C., Zhang, D. (2007). Molecular analysis of duck hepatitis virus type 1. Virology 361(1): 9-17. PMid:17300822
3
https://doi.org/10.1016/j.virol.2007.01.007
Tseng, C.H., Tsai, H.J. (2007). Molecular characterization of a new serotype of duck hepatitis virus. Virus Res. 126(1-2): 19-31. PMid:17292992
4
https://doi.org/10.1016/j.virusres.2007.01.012
Xu, Q., Zhang, R., Chen, L., Yang, L., Li, J., Dou, P. (2012). Complete genome sequence of a duck hepatitis a virus type 3 identified in eastern China. J Virol. 86(24): 13848. PMid:23166253 PMCid:PMC3503064
5
https://doi.org/10.1128/JVI.02651-12
Kim, M.C., Kwon, Y.K., Joh, S.J., Kim, S.J., Tolf, C., Kim, J.H., Sung, H.W., et al. (2007). Recent Korean isolates of duck hepatitis virus reveal the presence of a new geno- and serotype when compared to duck hepatitis virus type 1 type strains. Arch Virol. 152(11): 2059-2072. PMid:17701025
6
https://doi.org/10.1007/s00705-007-1023-0
Kim, M.C., Kim, M.J., Kwon, Y.K., Lindberg, A.M., Joh, S.J., Kwon, H.M. (2009). Development of duck hepatitis A virus type 3 vaccine and its use to protect ducklings against infections. Vaccine. 27(48): 6688-6694. PMid:19747575
7
https://doi.org/10.1016/j.vaccine.2009.08.092
Chen, P., Liu, J., Jiang, Y., Zhao, Y., Li, Q., Wu, L. (2014). The vaccine efficacy of recombinant duck enteritis virus expressing secreted E with or without PrM proteins of duck tembusu virus. Vaccine. 32(41): 5271-5277. PMid:25087676
8
https://doi.org/10.1016/j.vaccine.2014.07.082
Soliman, M., Alfajaro, M.M., Lee, M.H., Jeong, Y.J., Kim, D.S., Son, K.Y. (2015). The prevalence of duck hepatitis a virus types 1 and 3 on Korean duck farms. Arch Virol. 160(2): 493-498. PMid:25359107
9
https://doi.org/10.1007/s00705-014-2264-3
Vidor, E. (2007). The nature and consequences of intra-and inter-vaccine interference. J Comp Pathol. 137(Suppl 1): S62-S66. PMid:17560593
10
https://doi.org/10.1016/j.jcpa.2007.04.014
Shalaby, M.A., Ayoub, M.N.K., Reda, I.M. (1978). A study on a new isolate of duck hepatitis virus and its relationship to other duck hepatitis virus strains Vet Med J Cairo Univ. 26, 215- 221.
11
Hisham, I., Ellakany, H.F., Selim, A.A., Abdalla, M., Zain El-Abideen, M.A., Kilany, W.H., Ali, A., Elbestawy, A.R. (2020). Comparative pathogenicity of duck hepatitis A virus-1 isolates in experimentally infected pekin and muscovy ducklings. Front Vet Sci. 7, 234. PMid:32671102 PMCid:PMC7326108
12
https://doi.org/10.3389/fvets.2020.00234
Abd-Elhakim, M.A., Thieme, O., Schwabenbauer, K., Ahmed, Z.A. (2009). Mapping traditional poultry hatcheries in Egypt. In: AHBL - Promoting strategies for prevention and control of HPAI, FAO, ed. (Rome, Italy, Food and Agriculture Organisation of the United Nations (FAO).
13
https://www.fao.org/3/al684e/al684e00.pdf
Anonymous vaccines duck virus hepatitis. Available online at: http://www.cfsph.iastate.edu/ Vaccines/disease_list.php?disease=duck-virushepatitis, lang=e , USA, Iowa State University
14
Omar, D.M., Soliman, E.M., Abdrabo, M.A., Abotaleb, M.M., Yehia, N., Saied, D., Hassanin, A.I.H. (2021). Immunological studies on the inactivated duck virus hepatitis vaccines in ducks. Adv Anim Vet Sci. 9(12): 2021-2026.
15
https://doi.org/10.17582/journal.aavs/2021/9.12.2021.2026
Wen, X., Zhu, D., Cheng, A., Wang, M., Chen, S., Jia, R. (2018). Molecular epidemiology of duck hepatitis a virus types 1 and 3 in China, 2010-2015. Trans Bound Emerg. Dis. 65(1): 10-15. PMid:29076646
16
https://doi.org/10.1111/tbed.12741
Liu, R., Shi, S., Huang, Y., Chen, Z., Chen, C., Cheng, L., Fu, G., et al. (2019). Comparative pathogenicity of different subtypes of duck hepatitis A virus in Pekin ducklings. Vet Microbiol. 228, 181-187. PMid:30593365
17
https://doi.org/10.1016/j.vetmic.2018.11.030
World Organisation for Animal Health (OIE). (2017). Chapter 2.3.8. Duck virus hepatitis. In: Manual of diagnostic tests and vaccines for terrestrial animals [Internet]. [modified May 2017; cited December 2017]. Available from: http://www.oie.int/standardsetting/ terrestrial-manual/access-online/
18
Woolcock, P. (1991). Duck hepatitis virus type I studies with inactivated vaccines in breeder ducks. Avian Pathol. 20(3): 509-522. PMid:18680046
19
https://doi.org/10.1080/03079459108418788
Dungu, B., Brett, B., MaCdonald, R., Deville, S., Dupuis, L., Theron, J., Bragg, R. (2009). Study on the efficacy and safety of different antigens and oil formulations of infectious coryza vaccines containing an NAD-independent strain of Avibacterium paragallinarum. Onderstepoort J Vet Res. 76(3): 299-309. PMid:21105597
20
https://doi.org/10.4102/ojvr.v76i3.34
Gough, R.E., Spackman, D. (1981). Studies with inactivated duck virus hepatitis vaccines in breeder ducks. Avian Pathol. 10(4): 471-479. PMid:18770162
21
https://doi.org/10.1080/03079458108418497
Woolcock, P.R. (1989). Duck virus hepatitis. In Purchase H.G., et al (eds.): A Laboratory Manual for the Isolation and Identification of Avian Pathogens 3rd ed. (pp. 152-155). Dubuque, Kendall/Hunt Publishing Co.
22
https://doi.org/10.1016/0021-9975(92)90031-O
Reed, L.J., Muench, H.H. (1938). A simple method of estimating 50% end point. Am J Hyg. 27, 493-497.
23
https://doi.org/10.1093/oxfordjournals.aje.a118408
Jae-Hee, R., Min, K. (2018). Live attenuated duck hepatitis virus vaccine in breeder ducks: Protective efficacy and kinetics of maternally derived antibodies. Vet Microbiol. 219, 107-112. PMid:29778181
24
https://doi.org/10.1016/j.vetmic.2018.04.021
Woolcock, P.R., Chalmers, W.S.K., Davis, D. (1982). A plaque assay for duck hepatitis virus. Avian Pathol. 11(4): 607-610. PMid:18770226
25
https://doi.org/10.1080/03079458208436135
Min, K., Jae-Hee, R., Hyung-Kwan, J. (2018). Protective efficacy of a bivalent live attenuated vaccine against duck hepatitis A virus types 1 and 3 in ducklings Veterinary. Vet Microbiol. 214, 108-112. PMid:29408021
26
https://doi.org/10.1016/j.vetmic.2017.12.018
Zhang, Y., Wu, S., Liu, W., Hu, Z. (2023). Current status and future direction of duck hepatitis A virus vaccines. Avian Pathol. 52(2): 89-99. PMid:36571394
27
https://doi.org/10.1080/03079457.2022.2162367